CompletedNCT04126135
Cytisine or Nicotine Replacement to Support Smoking Cessation
About this title
Read the official source — NCT04126135Medication studyAges 18–100MongoliaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 100 years.
- Listed locations
- UlaanbaatarSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: January 27, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,307
- Sponsor
- Loma Linda University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Mongolia
- Age range
- From 18 Years to 100 Years
- Official registry ID
- NCT04126135
- Official title
Show the full official title
Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy (NRT) in the National Smoking Cessation Program of Mongolia: A Pragmatic Non-Inferiority Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ulaanbaatar
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Loma Linda University, a university.
Did this study involve medication?
Yes. The study involved medication, including Cytisine.
Who was this study for?
Listed age limits: 18 years to 100 years.
